If you take part in a clinical trial, you may get tests or treatments in a hospital, clinic, or doctor's office.
In some ways, taking part in a clinical trial is different from having regular care from your own doctor. For example, you may have more tests and medical exams than you would otherwise.
The purpose of clinical trials is research, so the studies follow strict scientific standards. These standards protect patients and help produce reliable study results.
Each clinical trial has a master plan called a protocol (PRO-to-kol). This plan explains how the trial will work. The trial is led by a principal investigator (PI), who often is a doctor. The PI prepares the protocol for the clinical trial.
The protocol outlines what will be done during the clinical trial and why. Each medical center that does the study uses the same protocol.
Key information in a protocol includes:
A clinical trial's protocol describes what types of patients are able to take part in the research—that is, who is eligible. Each trial must include only people who fit the patient traits for that study (the eligibility criteria).
Eligibility criteria differ from trial to trial. They include factors such as a patient's age and gender, the type and stage of disease, and whether the patient has had certain treatments or has other health problems.
Eligibility criteria ensure that new approaches are tested on similar groups of people. This makes it clear to whom a clinical trial's results apply. These criteria also are a safety measure. They ensure a trial excludes any people for whom the protocol has known risks that outweigh any possible benefits.
Clinical trials of new medicines or medical devices are done in phases. These phases have different purposes and help researchers answer different questions.
For example, phase I clinical trials test new treatments in small groups of people for safety and side effects. Phase II clinical trials look at how well treatments work and further review these treatments for safety.
Phase III clinical trials use larger groups of people to confirm how well treatments work, further examine side effects, and compare new treatments with other available treatments.
The researchers doing clinical trials take steps to avoid bias. "Bias" means that human choices or other factors not related to the protocol affect the trial's results.
In most clinical trials, researchers use comparison groups. This means that the patients taking part in a trial are assigned to one of two or more similar groups. Each group will receive different medical strategies.
For example, one group may get the current standard treatment for a condition, while another group gets a new treatment. Researchers can then compare the results to see whether one group has better outcomes than the other.
Using comparison groups also ensures that no one in a study is left without treatment for the sake of research.
Sometimes, when no accepted standard treatment exists for a condition, people in one group may receive a placebo (plah-SE-bo). This is an inactive product that looks like the test product. You'll be told if a placebo will be used in a study before you agree to take part.
Most clinical trials that have comparison groups use randomization. This involves assigning patients to different comparison groups by chance, rather than choice.
This method helps ensure that any differences observed during a trial are due to the different strategies being used, not to preexisting differences between the patients. Usually, a computer program makes the group assignments.
The term "masking" refers to not telling the clinical trial participants which treatment they're getting. Masking, or "blinding," helps avoid bias. For this reason, researchers also may not be told which treatments the patients are getting. However, trial records can quickly show this information if safety issues arise.
Children and Clinical Studies: Messages for researchers
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans.
December 26, 2012
Benefits of higher oxygen, breathing device persist after infancy
By the time they reached toddlerhood, very preterm infants originally treated with higher oxygen levels continued to show benefits when compared to a group treated with lower oxygen levels, according to a follow-up study by a research network of the National Institutes of Health that confirms earlier network findings, Moreover, infants treated with a respiratory therapy commonly prescribed for adults with obstructive sleep apnea fared as well as those who received the traditional therapy for infant respiratory difficulties, the new study found.
November 20, 2013
Gary H. Gibbons
New NHLBI Program Trains Scientists to Bring More Science Out of the Lab and into the Patient Care Marketplace
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.